DevvStream Corp. (DEVS) Stock Tumbles 68% After-Hours: Here Is What Is Going On - DevvStream (NASDAQ:DEVS

DevvStream’s Form 8-K says it received fairness opinions for the proposed three-party combination with XCF Global and Southern Energy Renewables. It also states the prior DevvStream–Southern merger agreement automatically terminated after required fairness opinions were received, as a contractual step under the April 13, 2026 Business Combination Agreement. The parties say the BCA remains in force and they expect to file an S-4 with the SEC in coming weeks.

DevvStream (DEVS), XCF Global (SAFX) and Southern Energy Renewables said the three-party business combination agreement remains in effect after media mischaracterized an SEC Form 8-K. They said fairness opinions were received and the prior merger agreement automatically terminated under the BCA. The parties expect to file an S-4 in coming weeks to seek shareholder approvals.

A proposed Illinois class action says Walmart allegedly stores customers’ voiceprints from calls to its automated interactive voice system without written notice, violating the Illinois Biometric Information Privacy Act. The suit was filed for Amber Smith, who called a local Walmart store in Dec 2025 and July 2026. A separate Illinois case also alleges unauthorized voiceprint handling.

The U.S. Justice Department and Tennessee’s attorney general intervened in CRH’s subsidiary APAC-Tennessee’s planned purchase of Standard Construction, alleging the deal could reduce competition and raise asphalt prices for the Tennessee DOT. As part of a settlement, APAC-Tennessee will divest two hot-mix asphalt plants in western Tennessee to Dunn Construction.

The FCC is drafting a rule that would ban imports of new Chinese-made optical transceivers used in US AI data centers, citing cybersecurity and data risks. Chinese firms supply about 60% of global modules, with Zhongji Innolight at ~27%. Reuters reported Coherent shares rose 47% after the news. Draft timing is unclear, with potential cost and supply impacts.

Medtronic (NYSE: MDT) said it expanded the CE Mark indication for its Affera Mapping and Ablation System with the Sphere-9 catheter to treat ventricular arrhythmias, including ventricular tachycardia and PVCs. The Sphere-9 catheter is the first CE-marked dual-energy, all-in-one mapping and ablation catheter for ventricular ablation. The FDA granted Breakthrough Device Designation, and the U.S. Sphere VT pivotal trial is enrolling.